Cited by 120MicroRNA in disease regulationSchizophrenia research and treatmentGenetics and Neurodevelopmental Disorders

The emerging role of microRNAs in schizophrenia and autism spectrum disorders

Open access
Mellios, Nikolaos, Sur, Mriganka·2012·Frontiers in Psychiatry

Abstract

MicroRNAs (miRNAs) are small non-coding RNAs conserved throughout evolution whose perceived importance for brain development and maturation is increasingly being understood. Although a plethora of new discoveries have provided novel insights into miRNA-mediated molecular mechanisms that influence brain plasticity, their relevance for neuropsychiatric diseases with known deficits in synaptic plasticity, such as schizophrenia and autism, has not been adequately explored. In this review we discuss the intersection between current and old knowledge on the role of miRNAs in brain plasticity and function with a focus in the potential involvement of brain expressed miRNAs in the pathophysiology of neuropsychiatric disorders.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fpsyt.2012.00039

Cites

108 of 119 references verified11 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Several experimental miRNA-based therapies for schizophrenia, MDD, anxiety, and neurodevelopmental disorders are currently under investigation.

    “In addition to HDAC inhibitors, several experimental miRNA-based therapies for psychiatric disorders like schizophrenia, MDD, anxiety, and neurodevelopmental disorders are currently under investigation (122).”

    From The clinical use of epigenetics in psychiatry: a narrative review of epigenetic mechanisms, key candidate genes, and precision psychiatry (2025) · cites this paper as [122]

    The Conclusion (page unavailable) discusses miRNAs as possible biomarkers and suggests that patient-derived neurons might help discover future treatment options. It does not report experimental miRNA-based therapies under investigation for schizophrenia, MDD, anxiety, or neurodevelopmental disorders. Searches for therapies, therapeutic treatment, depression, and anxiety found no passage establishing that claim. (LLM, conf=0.72)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Mellios, N., & Sur, M.
Affiliations
Massachusetts Institute of Technology (US)
Corresponding author
Mellios, Nikolaos
Venue
Frontiers in Psychiatry
Published
2012
Volume
3
Pages
39-39
ISSN
1664-0640 (ISSN-L)
OpenAlex
W2032798168
Cited by
120
References
93
Citations by year
2026: 4 · 2025: 4 · 2024: 4 · 2023: 4 · 2022: 5 · 2021: 6 · 2020: 7 · 2019: 8 · 2018: 10 · 2017: 10 · 2016: 13 · 2015: 14 · 2014: 18 · 2013: 10 · 2012: 3
FWCI
4.78
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Frontiers in Psychiatry (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
Keywords
microRNA, schizophrenia, autism spectrum disorder, neuroplasticity, synaptic plasticity, neuropsychiatric disorders, brain development, pathophysiology

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review